SJS Investment Consulting’s ARK Genomic Revolution ETF ARKG Stock Holding History

SJS Investment Consulting’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.6K	Hold	538	–	–	﹤0.01%	749
2026 Q1	$14.2K	Hold	538	–	–	﹤0.01%	743
2025 Q4	$15.6K	Hold	538	–	–	﹤0.01%	689
2025 Q3	$14.9K	Buy	538 +45	+9%	+$1.14K	﹤0.01%	571
2025 Q2	$12K	Buy	+493	New	+$10.8K	﹤0.01%	326
2024 Q4	–	Sell	-100	Closed	-$2.56K	–	1613
2024 Q3	$2.56K	Hold	100	–	–	﹤0.01%	689
2024 Q2	$2.35K	Buy	+100	New	+$2.52K	﹤0.01%	647
2024 Q1	–	Sell	-101	Closed	-$3.3K	–	1650
2023 Q4	$3.3K	Buy	+101	New	+$2.75K	﹤0.01%	488

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SJS Investment Consulting's ARKG Position: Q2 2026 in Review

SJS Investment Consulting held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 538 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

SJS Investment Consulting first reported a position in ARKG in Q4 2023 and has held it in 8 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

SJS Investment Consulting held 538 shares of ARK Genomic Revolution ETF worth $22.6K as of Q2 2026.
SJS Investment Consulting left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #749 holding.
SJS Investment Consulting first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 8 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.